Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Key takeaways
- Ricardo Pillai Sun, June 7, 2026 at 9:52 PM GMT+7 3 min read HIMS Is HIMS a good stock to buy?
- Read More: 15 AI Stocks That Are Quietly Making Investors Rich
- Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? Ricardo Pillai Sun, June 7, 2026 at 9:52 PM GMT+7 3 min read HIMS Is HIMS a good stock to buy? We came across a bearish thesis on Hims & Hers Health, Inc. on Valueinvestorsclub.com by Pridwen. In this article, we will summarize the bears’ thesis on HIMS. Hims & Hers Health, Inc. s share was trading at $27.51 as of June 2nd. HIMS’s trailing and forward P/E were 57.14 and 58.82 respectively according to Yahoo Finance.
Hims & Hers Health (HIMS) is a leading consumer telehealth platform focused on treatments for erectile dysfunction, hair loss, hormone therapy, and weight loss, but the bearish thesis argues that the company’s recent growth has been driven largely by an unsustainable GLP-1 compounding business rather than durable core fundamentals.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich